Collectively, these results showed that ATF5 transcriptionally upregulated PIK3AP1 and enhanced the PI3K/AKT/mTOR pathway to promote the survival of CTCL. The gene discussed is MTOR; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.